Teacher Retirement System of Texas Lowers Position in Medpace Holdings, Inc. (NASDAQ:MEDP)

Teacher Retirement System of Texas reduced its stake in Medpace Holdings, Inc. (NASDAQ:MEDP) by 49.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,280 shares of the company’s stock after selling 7,176 shares during the period. Teacher Retirement System of Texas’ holdings in Medpace were worth $2,419,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the stock. R Squared Ltd purchased a new stake in shares of Medpace in the 4th quarter valued at approximately $30,000. SBI Securities Co. Ltd. acquired a new stake in Medpace in the 4th quarter valued at approximately $31,000. Stone House Investment Management LLC purchased a new stake in Medpace in the third quarter valued at approximately $33,000. Jones Financial Companies Lllp lifted its stake in Medpace by 2,750.0% during the fourth quarter. Jones Financial Companies Lllp now owns 114 shares of the company’s stock worth $38,000 after purchasing an additional 110 shares in the last quarter. Finally, Lindbrook Capital LLC boosted its position in shares of Medpace by 27.6% during the fourth quarter. Lindbrook Capital LLC now owns 134 shares of the company’s stock worth $45,000 after buying an additional 29 shares during the period. Institutional investors and hedge funds own 77.98% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on MEDP shares. Robert W. Baird boosted their price objective on Medpace from $354.00 to $362.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Leerink Partnrs upgraded shares of Medpace to a “hold” rating in a research note on Monday. Finally, Leerink Partners began coverage on shares of Medpace in a research note on Monday. They issued a “market perform” rating and a $330.00 price objective for the company. Nine investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $376.30.

Medpace Stock Down 2.1 %

NASDAQ MEDP opened at $317.65 on Thursday. Medpace Holdings, Inc. has a 52 week low of $302.01 and a 52 week high of $459.77. The firm has a 50 day moving average of $336.81 and a two-hundred day moving average of $339.41. The stock has a market capitalization of $9.68 billion, a PE ratio of 25.15, a price-to-earnings-growth ratio of 3.81 and a beta of 1.47.

Medpace (NASDAQ:MEDP) last issued its earnings results on Monday, February 10th. The company reported $3.67 EPS for the quarter, topping analysts’ consensus estimates of $2.96 by $0.71. Medpace had a net margin of 19.17% and a return on equity of 51.48%. On average, equities research analysts expect that Medpace Holdings, Inc. will post 12.29 earnings per share for the current fiscal year.

Medpace Company Profile

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.